| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 1330-CD-050/CF | |||
| Carrier Free | 1330-CD-01M/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 5566-BP-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 669-FO-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 1245-GA-050/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 298-VS-005/CF | |||
| Carrier Free | 298-VS-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 1237-TW-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 870-LP-025/CF | |||
![Immunocytochemistry/Immunofluorescence: Antennapedia Control Peptide [NBP2-29334] - NBD inhibitory peptide but not Control peptide blocks constitutive NF-kB activation in human multiple myeloma cells. U266 cells were treated with 100 uM of Control (A & B) or NBD peptide (C & D) for 12 hr, cytospun, plated on glass slides, air dried for 1 hr at room temperature and fixed with cold acetone. Slides were blocked with 5% normal goat serum for 1 hr and then incubated with rabbit polyclonal anti-human p65 antibody (A & C) followed by Ig-Alexa 594 second step. In control peptide treated cells, p65 translocates to nucleus (A), whereas NBD peptide prevents translocation of p65 into the nucleus (C). B & D: Nuclear staining with DNA binding dye. (Courtesy of Dr. B.B. Aggarwal, MD Anderson Cancer Center, Houston, TX)](http://images.novusbio.com/fullsize/Antennapedia-Control-Peptide-Immunocytochemistry-Immunofluorescence-NBP2-29334-img0014.jpg "<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: Antennapedia Control Peptide [NBP2-29334] - NBD inhibitory peptide but not Control peptide blocks constitutive NF-kB activation in human multiple myeloma cells. U266 cells were treated with 100 uM of Control (A & B) or NBD peptide (C & D) for 12 hr, cytospun, plated on glass slides, air dried for 1 hr at room temperature and fixed with cold acetone. Slides were blocked with 5% normal goat serum for 1 hr and then incubated with rabbit polyclonal anti-human p65 antibody (A & C) followed by Ig-Alexa 594 second step. In control peptide treated cells, p65 translocates to nucleus (A), whereas NBD peptide prevents translocation of p65 into the nucleus (C). B & D: Nuclear staining with DNA binding dye. (Courtesy of Dr. B.B. Aggarwal, MD Anderson Cancer Center, Houston, TX)")